Mimedx (MDXG) Operating Income (2011 - 2026)
Mimedx recorded quarterly Operating Income of -$16.0 million in Q1 2026, down 176.14% quarter-over-quarter from $21.1 million in Q4 2025, and down 294.51% year-over-year from $8.3 million in Q1 2025.
Mimedx's Operating Income history runs 16 years deep, the most recent figure standing at -$16.0 million for Q1 2026.
- In Q1 2026, Operating Income fell 294.51% year-over-year to -$16.0 million; the TTM figure through Mar 2026 stood at $39.6 million (down 26.58% YoY), while the FY2025 annual figure was $63.9 million, up 8.53% from the prior year.
- Operating Income came in at -$16.0 million for Q1 2026 at Mimedx, down from $21.1 million in the prior quarter.
- In the past five years, Operating Income ranged from a high of $23.4 million in Q2 2024 to a low of -$16.0 million in Q1 2026.
- A 5-year average of $7.6 million and a median of $11.1 million in 2023 frame the typical range for Operating Income.
- Across the five-year window, Operating Income slumped 2250.24% in 2022 and surged 3981.76% in 2024, its largest moves.
- Mimedx's Operating Income stood at $11.3 million in 2022, then surged by 36.95% to $15.5 million in 2023, then slipped by 28.64% to $11.1 million in 2024, then soared by 90.67% to $21.1 million in 2025, then tumbled by 176.14% to -$16.0 million in 2026.
- According to Business Quant data, Operating Income over the past three periods registered -$16.0 million, $21.1 million, and $22.2 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Op. Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | -2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -19.70 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | -15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.14 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 642.90 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 268.64 Mn |
| 10 | Mimedx | 530.69 Mn | 370.92 Mn | 41.62 Mn | -16.05 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -16.05 Mn |
| Dec 31, 2025 | 21.08 Mn |
| Sep 30, 2025 | 22.19 Mn |
| Jun 30, 2025 | 12.37 Mn |
| Mar 31, 2025 | 8.25 Mn |
| Dec 31, 2024 | 11.05 Mn |
| Sep 30, 2024 | 11.16 Mn |
| Jun 30, 2024 | 23.45 Mn |
| Mar 31, 2024 | 13.20 Mn |
| Dec 31, 2023 | 15.49 Mn |
| Sep 30, 2023 | 11.12 Mn |
| Jun 30, 2023 | 10.84 Mn |
| Mar 31, 2023 | -340,000.00 |
| Dec 31, 2022 | 11.31 Mn |
| Sep 30, 2022 | -7.10 Mn |
| Jun 30, 2022 | -9.64 Mn |
| Mar 31, 2022 | -9.30 Mn |
| Dec 31, 2021 | 1.29 Mn |
| Sep 30, 2021 | -1.08 Mn |
| Jun 30, 2021 | -410,000.00 |
| Mar 31, 2021 | -6.85 Mn |
| Dec 31, 2020 | -16.09 Mn |
| Sep 30, 2020 | -9.71 Mn |
| Jun 30, 2020 | -5.86 Mn |
| Mar 31, 2020 | -13.74 Mn |
| Dec 31, 2019 | -4.87 Mn |
| Sep 30, 2019 | 14.20 Mn |
| Jun 30, 2019 | -17.07 Mn |
| Mar 31, 2019 | -13.41 Mn |
| Dec 31, 2018 | -8.94 Mn |
| Sep 30, 2018 | 373,000.00 |
| Jun 30, 2018 | 1.68 Mn |
| Mar 31, 2018 | 2.97 Mn |
| Dec 31, 2017 | 23.98 Mn |
| Sep 30, 2017 | 8.84 Mn |
| Jun 30, 2017 | 7.21 Mn |
| Mar 31, 2017 | 6.19 Mn |
| Dec 31, 2016 | -8.85 Mn |
| Sep 30, 2016 | 4.70 Mn |
| Jun 30, 2016 | 3.56 Mn |
| Mar 31, 2016 | 1.47 Mn |
| Dec 31, 2015 | 7.75 Mn |
| Sep 30, 2015 | 6.71 Mn |
| Jun 30, 2015 | 5.65 Mn |
| Mar 31, 2015 | 4.25 Mn |
| Dec 31, 2014 | 4.65 Mn |
| Sep 30, 2014 | 3.73 Mn |
| Jun 30, 2014 | -392,000.00 |
| Mar 31, 2014 | -891,000.00 |
| Dec 31, 2013 | -1.41 Mn |
| Sep 30, 2013 | -255,891.00 |
| Jun 30, 2013 | -744,217.00 |
| Mar 31, 2013 | -226,890.00 |
| Dec 31, 2012 | -972,394.00 |
| Sep 30, 2012 | -3.63 Mn |
| Jun 30, 2012 | -117,516.00 |
| Mar 31, 2012 | -631,365.00 |
| Dec 31, 2011 | -2.44 Mn |
| Sep 30, 2011 | -1.65 Mn |
| Jun 30, 2011 | -2.42 Mn |
| Mar 31, 2011 | -3.26 Mn |